 Bellerophon currently intends to use the net proceeds from this offering for working capital, general corporate purposes, and other research and development efforts. The shares were offered by Bellerophon pursuant to a shelf registration statement on Form S-3 that was initially filed on June 25, 2018 and declared effective by the Securities and Exchange Commission SEC on July 6, 2018 and the prospectus contained therein File No. 333-225878. 